Daqing Wu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 4, 2022 | NIH | STTR Phase II Small-molecule therapy for metastatic castration-resistant prostate cancer | $927K | METCURE THERAPEUTICS, LLC |
| Aug 19, 2021 | NIH | STTR Phase II Small-molecule therapy for metastatic castration-resistant prostate cancer | $1.0M | METCURE THERAPEUTICS, LLC |
| Jul 14, 2017 | NIH | STTR Phase I Small-molecule therapy for metastatic prostate cancer | $225K | METCURE THERAPEUTICS, LLC |
| Sep 19, 2016 | NIH | STTR Phase I Novel small-molecule targeted therapy for prostate cancer | $225K | METCURE THERAPEUTICS, LLC |
| Feb 23, 2015 | NIH | STTR Phase I A Dietary Supplement As Adjunct Therapy In Castration-Resistant Prostate Cancer | $161K | METCURE THERAPEUTICS, LLC |
Peer ranks
Federal funding#751
Awards as PI#417
Patents#273
Companies
- METCURE THERAPEUTICS, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.